These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 3113798

  • 1. Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa.
    Gullikson GW, Anglin CP, Kessler LK, Smeach S, Bauer RF, Dajani EZ.
    Clin Invest Med; 1987 May; 10(3):145-51. PubMed ID: 3113798
    [Abstract] [Full Text] [Related]

  • 2. [Protective effect of misoprostol on the changes of transgastric potential difference induced by aspirin in man].
    Bergmann JF, Simoneau G, Naudin R, Caulin C, Segrestaa JM.
    Rev Rhum Mal Osteoartic; 1991 Feb; 58(2):135-8. PubMed ID: 1904163
    [Abstract] [Full Text] [Related]

  • 3. Gastric mucosal blood flow in misoprostol pretreated aspirin-induced ulceration.
    Gana TJ, MacPherson BR, Koo J.
    Ann Surg; 1988 Mar; 207(3):327-34. PubMed ID: 3125802
    [Abstract] [Full Text] [Related]

  • 4. [Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
    Müller P, Dammann HG, Simon B.
    Arzneimittelforschung; 1986 Feb; 36(2):265-8. PubMed ID: 3083829
    [Abstract] [Full Text] [Related]

  • 5. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G, Hopkins A, Akbar FA.
    Postgrad Med J; 1988 Feb; 64 Suppl 1():60-77. PubMed ID: 3138682
    [Abstract] [Full Text] [Related]

  • 6. Morphological and physiological effects of a cytoprotective prostaglandin analog (rioprostil) on the rat gastric mucosa.
    Morris GP, Keenan CM, Shriver DA.
    Clin Invest Med; 1987 May; 10(3):121-31. PubMed ID: 3113797
    [Abstract] [Full Text] [Related]

  • 7. Misoprostol prevents damage to the gastric mucosa by stabilizing the mast cells.
    Reimann HJ, Lewin J, Schmidt U, Wendt P, Blueml G, Dajani EZ.
    Prostaglandins; 1987 May; 33 Suppl():105-16. PubMed ID: 2447610
    [Abstract] [Full Text] [Related]

  • 8. Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview.
    Dajani EZ, Nissen CH.
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):194S-200S. PubMed ID: 3932054
    [Abstract] [Full Text] [Related]

  • 9. Bile salt-induced, acute gastric mucosal damage in man: time course and effect of misoprostol, a PGE1-analogue.
    Fimmel CJ, Müller-Lissner SA, Blum AL.
    Scand J Gastroenterol Suppl; 1984 Nov; 92():184-8. PubMed ID: 6429843
    [Abstract] [Full Text] [Related]

  • 10. Overview of the mucosal protective effects of misoprostol in man.
    Dajani EZ.
    Prostaglandins; 1987 Nov; 33 Suppl():117-29. PubMed ID: 3122272
    [Abstract] [Full Text] [Related]

  • 11. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
    Wilson DE.
    Postgrad Med J; 1988 Nov; 64 Suppl 1():7-11. PubMed ID: 3138683
    [Abstract] [Full Text] [Related]

  • 12. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
    Lanza F, Peace K, Gustitus L, Rack MF, Dickson B.
    Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
    [Abstract] [Full Text] [Related]

  • 13. [Prophylactic effect of Misoprostol on gastric lesions induced by aspirin (ASA) in healthy subjects].
    Naves J, Santoyo R, Morales I.
    Rev Gastroenterol Mex; 1989 Feb; 54(4):203-6. PubMed ID: 2515571
    [Abstract] [Full Text] [Related]

  • 14. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
    Tsai BS, Keith RH, Perkins WE, Walsh RE, Anglin CP, Collins PW, Gasiecki AW, Bauer RF, Jones PH, Gaginella TS.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
    [Abstract] [Full Text] [Related]

  • 15. Comparative mucosal protective properties of misoprostol, cimetidine, and sucralfate.
    Bauer RF, Bianchi RG, Casler J, Goldstin B.
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):81S-85S. PubMed ID: 3080294
    [Abstract] [Full Text] [Related]

  • 16. Misoprostol preclinical pharmacology.
    Bauer RF.
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):118S-125S. PubMed ID: 3932042
    [Abstract] [Full Text] [Related]

  • 17. Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study.
    Silverstein FE, Kimmey MB, Saunders DR, Levine DS.
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):137S-141S. PubMed ID: 3080286
    [Abstract] [Full Text] [Related]

  • 18. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
    Wilson DE.
    Am J Med; 1987 Jul 27; 83(1A):2-8. PubMed ID: 3113241
    [Abstract] [Full Text] [Related]

  • 19. Aspirin-induced gastric mucosal damage in dogs: protection by the prostanoid Ro 22-1327.
    Gaginella TS, Davidovich A, Bertko RJ, Finckenor BA.
    Res Commun Chem Pathol Pharmacol; 1989 Dec 27; 66(3):385-95. PubMed ID: 2609016
    [Abstract] [Full Text] [Related]

  • 20. Gastric mucosal lesions produced by intravenous infusion of aspirin in cats.
    Bugat R, Thompson MR, Aures D, Grossman MI.
    Gastroenterology; 1976 Nov 27; 71(5):754-9. PubMed ID: 9330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.